PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 22: Articles 10501-11000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Oral contraceptive use and risk of cutaneous malignant melanoma. The authors' reply [letter]
  2. Oral contraceptive use does not raise breast cancer risk for women older than 40, Canadian data show.
  3. Oral contraceptive use in relation to chest and limb symptoms.
  4. Oral contraceptives -- can we make them more effective?
  5. Oral contraceptives and acquisition of HIV infection.
  6. Oral contraceptives and breast cancer.
  7. Oral contraceptives and cancer.
  8. Oral contraceptives and cancer. [Contraceptivos orales y cancer.]
  9. Oral contraceptives and cardiovascular disease. [Anticonceptivos orales y enfermedad cardiovascular.]
  10. Oral contraceptives and cerebral thromboembolism. A Danish case-control study. [P-piller og cerebral tromboemboli. Et dansk case-kontrol-studium.]
  11. Oral contraceptives and endometrial cancer.
  12. Oral contraceptives and endometrial cancer: do other risk factors modify the association?
  13. Oral contraceptives and fatal thromboembolism in young women [letter]
  14. Oral contraceptives and malignant melanoma.
  15. Oral contraceptives and plasma lipoprotein metabolism.
  16. Oral contraceptives and reproductive factors in multiple sclerosis incidence.
  17. Oral contraceptives and the dexamethasone suppression test.
  18. Oral contraceptives and the risk of gallbladder disease: a meta-analysis.
  19. Oral contraceptives and the risk of sexual acquisition of HIV-1 infection by women: a review of studies from Kenya.
  20. Oral contraceptives and the woman over 35. [Los contraceptivos orales y la mujer de mas de 35 anos.]
  21. Oral contraceptives effect on glucose metabolism.
  22. Oral contraceptives for the prevention of osteoporosis.
  23. Oral contraceptives for women over the age of 35.
  24. Oral contraceptives in Latin America. [Anticonceptivos orales en America Latina.]
  25. Oral contraceptives in relation to breast cancer.
  26. Oral contraceptives may increase risk of HIV transmission.
  27. Oral contraceptives off prescription [letter]
  28. Oral contraceptives without prescription [letter]
  29. Oral contraceptives without prescription [letter]
  30. Oral contraceptives without prescription [letter]
  31. Oral contraceptives: are drug interactions of clinical significance?
  32. Oral contraceptives: effect on hemostasis.
  33. Oral contraceptives: knowledge and compliance. [P-piller: viden og komplians.]
  34. Order of 30 January 1991 of the Office of the Counsellor for Health and Consumer Affairs regulating the provision of family planning services within the framework of hospital care.
  35. Order of 5 November 1992 on family planning or education centres.
  36. Organization of family planning services on a regional level, and issues in its development. [Organizatsiia sluzhby planirovaniia semi na regionalnom urovne i zadachi po ee razvitiiu.]
  37. Organizational aspects of Turkey's mass media family planning campaign.
  38. Organizing for effective family planning programs.
  39. Outreach and accessibility of family planning methods in rural Uttar Pradesh.
  40. Over-the-counter female contraceptives lose sales as prescription products gain.
  41. Over-the-counter oral contraceptives -- an immodest proposal? [editorial]
  42. Overview of family planning.
  43. Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol.
  44. Pakistan's low contraceptive use tied to medical issues.
  45. Pakistan: Family Planning with Male Involvement Project of Mardan.
  46. Pamela Maraldo taking Planned Parenthood?
  47. Participation of men and women in family planning in Latin America. [Participación de hombres y mujeres en la planificación familiar en América Latina.]
  48. Patterns of birth control.
  49. Patterns of contraceptive use and method choice in China.
  50. Patterns of contraceptive use and pregnancy among young Hispanic women on the Texas-Mexico border.
  51. Pedaling to San Lucas de Toliman. Family planning finds unusual ways to reach rural communities.
  52. Pelvicoabdominal actinomycosis associated with an intrauterine contraceptive device. A case of liver dissemination mimicking metastatic ovarian cancer.
  53. People like you never agree to get it: an Indian family planning clinic.
  54. People need contraception because they have sex.
  55. People's major concern. The decision of couples to practice family planning is more influenced by the teachings in school and the advice given by physicians.
  56. Perceived factors of family planning clinic performance and service quality.
  57. Perceptions of traditional birth attendants regarding contraceptive methods.
  58. Perth: contraceptive use and unplanned pregnancy survey.
  59. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
  60. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
  61. Pharmacology of contraceptive steroids.
  62. Phase I clinical trial of an injectable contraceptive for the male.
  63. Philippines. Final report. Education and Information Television Series for WOMANWATCH on Safe Motherhood, Women's Health, and Family Planning. Sub-agreement between the Johns Hopkins University, Population Communication Services and the Women Media Circle Foundation, Inc., May 15, 1992 - December 31, 1992, AS-PHI-17.
  64. Philippines. Final report. Structured Stambayans for Family Planning Promotion in Selected Barangays of Legazpi City and Albay. Subagreement between the Johns Hopkins University Population Communication Services and the AGO Medical and Educational Center (AMEC), Bicol Christian College of Medicine, March 1, 1988 - August 31, 1990, AS-PHI-05.
  65. Philippines. Final report. The "Pagtatap sa Panimalay" (Caring for the Family) project. Subagreement between the Johns Hopkins University / Population Communication Services and the Family Planning Organization of the Philippines, May 1990 - August 1991, AS-PHI-09.
  66. Planned Parenthood of Southeastern Pennsylvania v. Robert P. Casey. [Excerpts]
  67. Planned Parenthood v Casey [letter]
  68. Planned Parenthood v Casey [letter]
  69. Planned Parenthood v Casey. The impact of the new undue burden standard on reproductive health care.
  70. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
  71. Policy and standards for maternal and child / family planning services. 2nd ed. [Politique et standards des services de sante maternelle et infantile et planification familiale. Second edition.]
  72. Policy issues in expanding private sector family planning.
  73. Political and economic factors influencing contraceptive uptake.
  74. Politics and ethics in family planning.
  75. Population and development in Egypt. (4). Features of the Egyptian Family Planning Program.
  76. Population and family planning policies: women-centred perspectives.
  77. Population picks and pans. Population Action International's 1992 selection of the ten countries worldwide making the most and least progress in family planning.
  78. Population policy and Parliament: debates and decisions on birth control. [Politica demografica e Parlamento. Debates e decisoes sobre o controle da natalidade.]
  79. Population, family planning, and women's health: finding and pursuing common goals.
  80. Portal vein thrombosis associated with prolonged ingestion of oral contraceptive steroids.
  81. Post-abortion family planning: reversing a legacy of neglect.
  82. Postabortal contraception.
  83. Postabortion contraception: few family planning services available.
  84. Postcoital contraception. [La contraception post-coitale.]
  85. Postpartum contraception. Unnecessary before three weeks [letter]
  86. Postpartum contraception: informed choice.
  87. Poverty and use of contraceptive methods.
  88. Practice of postcoital contraception -- the results of a national survey.
  89. Pre-test of storyboards for the family planning campaign. Final report of focus groups. [Pre-test des storyboards de la campagne de planification familiale. Rapport final des focus groupes.]
  90. Pregnancy and birth control in CAPD patients.
  91. Pregnancy associated with a combined oral contraceptive and itraconazole [letter]
  92. Pregnancy due to the failure of the hormonal contraceptive method (letter) [Embarazo por fallo del metodo anticonceptivo hormonal.]
  93. Pregnancy termination and contraceptive failure in Viet Nam.
  94. Pregnancy, contraception and epilepsy. [Schwangerschaft, Antikonzeption und Epilepsie.]
  95. A preliminary report of Norplant implant insertions in a large urban family planning program.
  96. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.
  97. Preparing for privatization of the Peruvian social security system: a feasibility test of introducing family planning into private health providers.
  98. The prescription of contraceptives for immigrant women in France. [Prescription de contraception aux femmes immigrees en France.]
  99. Present possibilities of hormonal contraception. [Soucasne moznosti hormonalni antikoncepce.]
  100. Prevalence is not enough: the importance of appropriateness of contraceptive method in evaluating unmet need for contraception.
  101. Prevalence of cervical Chlamydia trachomatis infection in a female population seeking contraceptive counseling. [Prevalence de l'infection cervicale a Chlamydia trachomatis dans une population feminine consultant pour contraception.]
  102. Preventing maternal mortality through family planning.
  103. Priority area 5: family planning.
  104. The Private Practitioners' Family Planning Project media campaign evaluation. Volume One: The public survey (draft report)
  105. Private-sector involvement in family planning services in Ghana.
  106. Problems in distribution of scientific knowledge: intrauterine contraceptive devices and drug catalogs.
  107. Proceedings of the South Asia Population Communication Conference. Jiggasha. A Community Network Approach to Family Planning, February 8-11, 1993, Sonargaon Hotel, Dhaka, Bangladesh.
  108. Proceedings of the Twenty-Fifth Annual Conference, Association for Population/Family Planning Libraries and Information Centers--International: population and environment.
  109. A process for quality improvement in family planning services.
  110. PROFAMILIA's proven ability to bring family planning to the Dominican Republic.
  111. Profile and prospects of the intrauterine contraceptive (IUD)] [Perfil y horizonte de la anticoncepcion intrauterina.]
  112. Profile of family planning method users, discontinuation of these methods. [Profil des utilisatrices des methodes de P.F., abandon de ces methodes.]
  113. Programme advisory note on management information systems in support of family planning programmes.
  114. Promoting breastfeeding as birth control.
  115. Promoting family planning among high risk women.
  116. Promoting the role of Raidat Riefiat in family planning program (O.R. study)
  117. Promotion and delivery of family planning in the Donga-Mantung: an operations research (OR) study on the role of male opinion leaders.
  118. Promotion of breastfeeding and family planning in the Social Security Institute of Honduras.
  119. Promotion of family planning for better family living.
  120. A proposed method for estimating contraceptive effectiveness.
  121. Prospective European multi-center study of natural family planning (1989-1992): interim results.
  122. A prospective randomized study comparing the clinical effects of a norethisterone and a levonorgestrel containing low dose oestrogen oral contraceptive pills.
  123. A prospective study of condom use in family planning clients.
  124. Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception.
  125. Protectaid contraceptive sponge with F-5 gel.
  126. Protection for family planning clinics.
  127. Protein C activity in healthy volunteers -- influence of age, sex, smoking and oral contraceptives.
  128. Protocols for family planning services. [Protocoles des services de planification familiale.]
  129. Providing an appropriate contraceptive method choice. What health workers need to know.
  130. Providing family planning services on the basis of reproductive risk.
  131. Providing the foundation for the development of self-sustaining family planning services: FPMD and FEMAP.
  132. Provision of natural family planning methods through comprehensive health care systems.
  133. Provision of STD services in maternal and child health and family planning settings. Integration of STD services within gender-specific clinical settings. Report of an internal WHO / GPA meeting.
  134. Psoas abscess related to spontaneous abortion, intra-uterine contraceptive device and curettage.
  135. Psycho-social determinants of contraceptive initiation in India.
  136. Publicly supported family planning in the United States. Financing of family planning services.
  137. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
  138. The purposes and processes of planning in the Indonesian Family Planning Program.
  139. Qualitative research for family planning programs in Africa.
  140. Quality contraception or sexual health care? A survey of family planning clinic managers in one health region.
  141. Quality of care and family planning drop-outs in Bukidnon province: a survey study.
  142. Quality of care and women's perspective and needs for post-abortion family planning services: a Sierra Leone experience.
  143. Quality of care in family planning in Latin America.
  144. Quality of care in family planning programmes: a rapid assessment in Burkina Faso.
  145. Quality of care in family planning: a catalog of assessment and improvement tools.
  146. Quality of care in family planning: clients' rights and providers' needs.
  147. Quality of care in family planning: standards, yes. Standard, no.
  148. Quality of family planning services offered in Yaounde and Douala.
  149. Quality of Norplant contraceptive services in Indonesia.
  150. The quest for a herbal contraceptive.
  151. Question of the month: Behcet disease and contraception. [La question du mois: maladie de Behcet et contraception.]
  152. Replication of Johns Hopkins IEC interventions in the Asia Foundation supported NGO family planning program.
  153. Report on the preliminary KAP survey of family planning project for promotion of population education.
  154. Report: Workshop on Operations Research Priorities in Family Planning.
  155. Reproductive ethnophysiology and contraceptive use in a rural Micronesian population.
  156. Research findings on post-abortion counselling and family planning: lessons learnt from the South-to-South multicentre study.
  157. Research on contraception and family planning. Editor's introduction.
  158. Research on natural family planning: a study of cervical mucus, vaginal smear, estogen and progesterone excretion in the urine in the normal menstrual cycle.
  159. Residential mobility and contraceptive use in northeastern Brazil.
  160. Respecting the autonomy of chronic mentally ill women in decisions about contraception.
  161. Restructuring federalism: the impact of Reagan policies on the family planning program.
  162. Restructuring federalism: the impact of Reagan policies on the family planning program.
  163. Review of existing family planning policies and programs: lessons learned.
  164. A review of family planning in Ireland.
  165. Review of family planning in Uttar Pradesh: a synthesis paper.
  166. A review of lessons learned in successful international family planning programs.
  167. Reviewing family planning services: a method for population based outcome-related needs assessment.
  168. Revised oral contraceptive labeling: FDA approves recommendation allowing delay of pelvic exam.
  169. Rheumatoid arthritis, the contraceptive pill, and androgens.
  170. Risk and contraception: what women are not told about tubal ligation.
  171. Risk of an unwanted pregnancy following a single unprotected coitus; observations on the current hormonal postcoital contraceptive methods (letter) [Het risico van een onbedoelde zwangerschap na een obeschermde coitus; beschouwing bij de huidige hormonale postcoitale anticonceptiemethoden.]
  172. Risk of an unwanted pregnancy following a single unprotected coitus; observations on the current hormonal postcoital contraceptive methods (letter) [Het risico van een onbedoelde zwangerschap na een onbeschermde coitus; beschouwing bij de huidige hormonale postcoitale anticonceptiemethoden.]
  173. Risk of an unwanted pregnancy following a single unprotected coitus; observations on the current hormonal postcoital contraceptive methods] [letter.
  174. Risk of cerebral thrombosis is less for lower dose oral contraceptives than for higher dosage pills.
  175. Risks of oral contraceptive use in women over 35.
  176. The role of population factors in planning government expenditures: the case of the health / family planning sector.
  177. Role of service-based program statistics in assessment of family planning program.
  178. Rosenberg and colleagues respond concerning "Barrier Contraceptives and Sexually Transmitted Diseases in Women: a Comparison of Female-Dependent Methods and Condoms" [letter]
  179. Roundtable: advances in hormonal contraception. [Mesa redonda: avances en anticoncepcion hormonal.]
  180. Rural Thai social setting and family planning activity: effects on female sterilization.
  181. Rural-to-urban migration in Bolivia and Peru: associations with child mortality, breast-feeding cessation, maternal care and contraception.
  182. The Russian Family Planning Association.
  183. Safe motherhood and family planning.
  184. Safe Motherhood Initiative and family planning associations.
  185. Safety issues in voluntary female surgical contraception: peri-operative complications.
  186. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia.
  187. Safety, efficacy, and control of the menstrual cycle by a monophasic oral contraceptive containing 75 mcg of gestodene and 30 mcg of ethinyl estradiol. [Seguridad, efectividad y control del ciclo menstrual de una preparacion anticonceptiva oral monofasica con 75 mcg de gestodeno y 30 mcg de etinilestradiol.]
  188. Satisfied users as family planning motivators for pills and IUDs.
  189. Selected figures and tables from the evaluation of the Family Planning Communication Project in Ghana, December 1989 to November 1991.
  190. Seminars offer key to better family planning.
  191. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
  192. Service provider attitudes toward natural family planning.
  193. Setting agendas in contraceptive research. Mexico City symposium.
  194. Seventeen-year review of sexual and contraceptive behavior on a college campus.
  195. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
  196. Sex steroids, sexual behavior, and selection attention for erotic stimuli in women using oral contraceptives.
  197. The sexual and contraceptive lifestyles of young people: part II.
  198. Sexual and contraceptive practice in an Irish university.
  199. Sexual behavior, contraception and the risk of contracting HIV.
  200. Sexual behaviour and contraceptive practices of year 10 schoolgirls in inner metropolitan Sydney.
  201. Sexual risk and perception of risk for HIV infection among multiethnic family-planning clients.
  202. Sexuality: sexual activity and contraception during adolescence.
  203. Sexually transmitted diseases and family planning [letter]
  204. Sexually transmitted diseases and family planning. Strange or natural bedfellows, revisited [editorial]
  205. Should oral contraceptives be available without prescription?
  206. Should oral contraceptives be sold over-the-counter?
  207. Sickle cell disease and contraception [letter]
  208. The simulated client method: evaluating client-provider interactions in family planning clinics.
  209. The simulated client method: evaluating client-provider interactions in family planning clinics.
  210. Singing about family planning.
  211. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
  212. SIS / IEC in Egypt. The challenging task of family planning.
  213. Situation analysis in Burkina Faso family planning programme.
  214. A situation analysis of the family planning service delivery system.
  215. A situation analysis study of family planning service delivery points in Ghana. Draft.
  216. Six years of clinical experience using postcoital contraception in college women.
  217. Sixty years ago -- birth control controversies in the "Queen of the Suburbs".
  218. Social comparison and the pill: reactions to upward and downward comparison of contraceptive behavior.
  219. The social context of contraceptive use among high school adolescents in Kenya.
  220. Social marketing's expansion to long-term methods: what does it mean for family planning programs?
  221. Social, cultural and medical determinants of contraceptive use. Overview.
  222. Socio-cultural dimensions of contraceptive use in Kuwait.
  223. SOGC says regulatory agencies stalling on approval of safe, effective contraceptives.
  224. Some methodological considerations of a progestin-only oral contraceptive study from a programmatic perspective.
  225. Some notes on male participation in the Indonesian family planning program.
  226. Sona Bata: community-based distribution (CBD) vs. dispensary-based distribution of family planning services.
  227. Sonographic dating of pregnancies conceived after contraceptive pill therapy.
  228. A special obligation -- access to contraception.
  229. Speech: briefing on China's population situation at present and the implementation of the family planning program.
  230. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
  231. The state and population: a history of family planning in Brazil. [Estado e populacao: uma historia do planejamento familiar no Brasil.]
  232. Status of women and family planning in China and India.
  233. The status of women, fertility and family planning among tribals of South Rajasthan.
  234. STD and contraception.
  235. Sterilisation failures in voluntary female surgical contraception.
  236. Sterilization pellets seek contraceptive credibility.
  237. Strategic planning for the expansion of family planning.
  238. Strategies for increasing male involvement in family planning in Nigeria: a concept paper. Draft.
  239. Strategies for reducing male opposition to family planning.
  240. Strategies for successful implementation of family planning programmes.
  241. Strategies of contraceptive use during fertility transitions.
  242. Strategies to increase the use of contraceptives by factory workers in Barbados.
  243. Strengthening ayurvedics' role as family planning providers.
  244. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
  245. Studies on the contraceptive efficacy of Praneem polyherbal cream.
  246. Study and introduction of family planning methods in developing countries.
  247. A study of contraceptive practice in Algeria, 1967-1987. [Essai de reconstitution de la pratique contraceptive en Algerie durant la periode 1967-1987.]
  248. A study of vaginal cytograms and LH bioassay on the application of Billings natural family planning for fertility regulation.
  249. Sub-50 oral contraceptives affect folate kinetics.

     

  250. Subdermal contraceptive implants in nurse-midwifery practice.
  251. Success of Morocco's oral contraceptive campaign encourages MOH to allow advertising on public channels.
  252. Summary of drug interactions with oral contraceptives.
  253. Summary on Distinguished Lecturers Symposium and Guest Lectures on Contraception (7-8 October 1992)
  254. Summary: Principal advantages and disadvantages of contraceptive methods. [Synthese: avantages et inconvenients principaux des methodes contraceptives.]
  255. Supply side determinants of family planning clinic utilization: findings from African situation analysis studies.
  256. Surgical contraception in Vietnam in the decade of the 90s.
  257. Surgical contraception: the kindest cut of all? [editorial]
  258. A survey of community based family planning and well woman services in Leeds.
  259. Survey on research concerning users' perspectives on contraceptive services, with emphasis on Sub-Saharan Africa.
  260. Survey on the continuity of contraception in Algiers. [Enquete sur la continuite de la contraception a Alger.]
  261. The switch is on from contraceptive foam to film.
  262. Tackling the problems of migration and an ageing population. Many Eastern Europeans denied access to contraception.
  263. Tanzania assessment: Program for Permanent and Long-Term Contraception, November 1-12, 1993.
  264. Tanzania Family Planning Communication Project: 1992 baseline clinic study.
  265. Tanzania: the family planning situation analysis study.
  266. Target setting in family planning programme: problems and potential alternatives.
  267. Target-Cost: a model for projecting the family planning service requirements and costs to achieve demographic goals. Revised ed.
  268. The TCu-380A (AG), MLCu375, and Nova-T IUDS and the IUD daily releasing 20 micrograms levonorgestrel -- four pillars of IUD contraception for the nineties and beyond?
  269. Teen sex, AIDS, and contraception [editorial]
  270. Teenage sexual and contraceptive behavior: the case of Mexico.
  271. Television could be effective in the family planning program in Rwanda. [La television pourrait etre efficace au programme de planning familial au Rwanda.]
  272. Ten factors that made Thailand's family planning programme a resounding success.
  273. The tenth national study event on abortion and contraception. [Dixiemes journees nationales d'etudes sur l'avortement et la contraception.]
  274. Testing elasticity of contraceptive prices in Thailand.
  275. Thailand: a case study of the financing of family planning services and family planning programme sustainability.
  276. Thailand: National Family Planning Program.
  277. To maximize contraceptive prevalence keep prices low.
  278. Today's IUDs offer safe, effective contraception.
  279. Too many children? Fertility and family planning in a Muslim society of Kenya.
  280. Towards effective contraceptive practice.
  281. Tradition not against family planning -- Ooni.
  282. Traditional methods of family planning. [Les methodes de PF traditionnelles.]
  283. Training course in women's health. 2nd ed. Module 7. Breastfeeding and the lactational amenorrhea method of family planning.
  284. Training in family planning.
  285. A training program to develop the capacity of maternal and child health / family planning (MCH/FP) program staff and university researchers that undertake operations research (OR)
  286. Training without literature. Training manual for family planning instructors in rural areas. [Capacitando sin letras. Manual de capacitacion para instructores de planificacion familiar, en areas rurales.]
  287. Transactional price of an expected child and its application in birth control.
  288. The transition to sustainable family planning programs.
  289. Translocation of an intrauterine contraceptive device to an unusual site.
  290. Trends in population and contraception.
  291. Trends in the costs of the family planning program in Egypt. The costs of family planning activities which received funding from the public sector.
  292. Trip report. Family Planning Association of Uganda, Radio Scriptwriters' Workshop, Kampala, Uganda, Dates of in-country work: July 27 - August 17, 1993.
  293. Trip report: research technical assistance. Innovations in Family Planning Services and Indian Medical Association projects.
  294. Turkey's CSM project stimulates a dramatic shift in low-dose oral contraceptive use through its "multi-manufacturer" model.
  295. Turkey's mass media family planning campaign.
  296. Two reasonable people: joint decisionmaking in contraceptive choice and use.
  297. Two world religions and family planning.
  298. Uganda. Family planning and maternal health service delivery: a guide for nurse aides.
  299. Ultrasonographic identification of an ectopic intrauterine contraceptive device within the bladder. A case report.
  300. Ultrasound evaluation of ovarian activity under oral contraceptives.
  301. Unmet demand for family planning.
  302. Unmet family planning demand: evidence from two sites in Kenya.
  303. Unmet need for contraception in Pakistan: pattern and determinants.
  304. Unmet need for family planning in India -- voices from the field.
  305. Unmet needs in family planning: youth (an Indian viewpoint)
  306. Unrecognized perforation of the uterine and rectal walls by an intrauterine contraceptive device.
  307. Unsafe sex and contraception among students from France, Quebec and Spain. [Sexualite a risque et contraception chez des etudiants de France, du Quebec et d'Espagne.]
  308. Unwanted pregnancy, abortion and post-abortion family planning in Zimbabwe: community, patient and provider perspectives. Introduction.
  309. Up to what age can we prescribe combined estrogen / progestin contraception? [Jusqu'a quel age peut-on prescrire la contraception estro-progestative?]
  310. Update on oral contraception.
  311. Urban literate lead transition to new reproductive pattern. The value of contraception in birth spacing.
  312. The use of contraceptives in Brazil: an analysis of the prevalence of female sterilization. [O uso de contraceptivos no Brasil: uma analise da prevalencia da esterilizacao feminina.]
  313. Use of hormonal contraceptives in an institutional setting: reasons for use, consent and safety in women with psychiatric and intellectual disabilities.
  314. Use of hormonal oral contraceptives in the perimenopause. [Utilizacion de la anticoncepcion hormonal oral en la perimenopausia.]
  315. The use of natural family planning methods on Mauritius island.
  316. Use of oral contraceptives and smoking among Danish women (editorial) [P-pillebrug og rygevaner blandt danske kvinder.]
  317. Use of oral contraceptives by adolescents in Finland [letter]
  318. Use of oral contraceptives in Denmark 1980-1990 and smoking habits among fertile women in 1990. [P-pillebrug i Danmark 1980-1990 samt rygevaner blandt fertile kvinder i 1990.]
  319. The use of quality management systems to institutionalize operations research in family planning organizations.
  320. The use of self-evaluation forms to improve the family planning program of the Ministry of Health of Guatemala.
  321. Use-effectiveness of oral contraceptives and quality of care.
  322. User fees for sustainable family planning services. Background discussion for the Handbook for Program Managers. Rev. ed.
  323. Using community health workers and rally posts for family planning outreach.
  324. Using data on client-provider interactions to assess the quality of family planning services.
  325. Using progestin-only oral contraceptives in Asian women -- some programmatic and methodological considerations.
  326. Using self-assessment to improve the family planning program of Guatemala. Operations research final report (Sub-agreement No. CI91.73A), September 15, 1991 - November 15, 1993. Prepared by Family Planning Unit / Ministry of Health and Public Assistance and INOPAL II / The Population Council.
  327. Using self-assessment to improve the quality of family planning clinic services.
  328. Using service statistics and quality of care data: a case study for training family planning managers.
  329. Using situation analysis as a strategy to strengthen managerial innovation in the family planning (FP) program of Nigeria.
  330. Using television dramas to accelerate social change: the enter-educate approach to family planning promotion in Turkey, Pakistan, and Egypt.
  331. Uzbekistan: family contraceptive counselling.
  332. Vaginal contraception with steroids. [La voie vaginale contraceptive par steroides ovariens.]
  333. Vaginal contraceptive rings.
  334. The value of family planning user profiles in better targeting of family planning: the case of Vanuatu.
  335. Vietnam's family planning programme. Population stabilization by the year 2045?
  336. Visible changes. Family planning in the Philippines regains its role as a key program in national development.
  337. Voices of acceptors. How family planning has touched the lives of five Filipino couples.
  338. Volunteers in the Indonesian Family Planning Program.
  339. Walsh v. Family Planning Services Ltd., Orr and Kelly [9 April 1992]
  340. We don't talk about it] Qualitative research on knowledge, attitudes and practices concerning pregnancy, family planning and maternal care in the Koila sector. Final report. ["N'en parlons pas]" Recherche qualitative sur les connaissances, attitudes et pratiques concernant la grossesse, le planning familial et les soins maternels dans le secteur de Koila. Rapport final.]
  341. What contraception for diabetic women? [Quelle contraception pour les femmes diabetiques?]
  342. What family planning methods women use and why they change them.
  343. What postpartum women think about contraception, conception and sexuality: a cross cultural study from South Africa.
  344. Which contraceptive methods are suitable for the older woman?
  345. Which oral contraceptive pill should be prescribed?
  346. Whose life is it, anyway? Assessing the relative risks of contraception and pregnancy.
  347. Why do projections of the cost of family planning differ so widely?
  348. Why family planning in Africa? [Pourquoi la planification familiale en Afrique?]
  349. Willing to pay for family planning service. Indonesia.
  350. Women and family planning. [Mujer y planificacion familiar.]
  351. Women and men in family planning (a general framework on gender perspectives) [Mujeres y hombres ante la planificación familiar (un marco global sobre la perspectiva de género)]
  352. Women at risk of unintended pregnancy, 1990 estimates: the need for family planning services, each state and county.
  353. Women status, fertility and family planning in Egypt.
  354. Women's contraceptive attitudes and use in 1992.
  355. Women's health and family planning.
  356. Women's satisfaction with birth control.
  357. Women's social network and family planning formative research proposal: Child Spacing Project, Cameroon.
  358. Women's use of condoms doubles since '84, birth control study finds.
  359. Women, contraception and HIV.
  360. Work experience and fertility patterns: a study from the 1987 Indonesia National Contraceptive Prevalence Survey.
  361. Worker-client exchanges and contraceptive use in rural Bangladesh.
  362. World Neighbors case study: Is reproductive health a sustainable rural development strategy? An analysis of a family planning project in Nepal.
  363. World's first non-hormonal contraceptive.
  364. Youth and family planning in Latin America. [Juventud y planificación familiar en América Latina.]
  365. Zaire: Contraceptive Social Marketing Project.
  366. Zimbabwe: Zimbabwe National Family Planning Council Program.
  367. Existence of multiple peaks in plasma ethinyl estradiol and norethindrone after oral administration of a contraceptive pill.
  368. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms.
  369. Bringing parents into school clinics: parent attitudes toward school clinics and contraception.
  370. Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate.
  371. The androgenicity of oral contraceptives: the young patient's concerns.
  372. Assessment of ovarian activity in a gestodene containing triphasic oral contraceptive.
  373. Attitudes to oral contraception in family planning attenders.
  374. Awareness and practice of contraception among female students at the Institute of Management and Technology (IMT), Enugu.
  375. A case-control study of the risk of breast cancer in relation to oral contraceptive use.
  376. Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol.
  377. Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen.
  378. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
  379. A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
  380. Contraception after heart surgery.
  381. Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study.
  382. Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients.
  383. Contraceptive use among postpartum women: recent patterns and programmatic implications.
  384. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics.
  385. Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent.
  386. Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. [Depósito para la liberación lenta de acetato de medroxiprogesterona (DMPA, depot-medroxyprogesterone acetate) y riesgo de cáncer cervical invasivo a células escamosas. Estudio colaborativo de la OMS sobre neoplasia y anticonceptivos esteroideos.]
  387. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
  388. Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic.
  389. Effect of "missed" pills on oral contraceptive effectiveness.
  390. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.
  391. Epidemiology of the noncontraceptive effects of oral contraceptives.

     

  392. Family planning in St Vincent, West Indies: a population history perspective.
  393. Fertility and family planning in Southern and Central Africa.
  394. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives.
  395. Genital tract infections associated with the intrauterine contraceptive device can be reduced by inserting the threads into the uterine cavity.
  396. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.
  397. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: analysis of TCu-380A acceptors in developing countries.
  398. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
  399. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
  400. Is the contraceptive effect of 300 micrograms of norethisterone mainly peripheral or central?
  401. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
  402. A norgestimate-containing oral contraceptive: review of clinical studies.
  403. Oral contraceptive type and functional ovarian cysts.
  404. Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use.
  405. Oral contraceptive use and risk of uterine fibroids.
  406. Oral contraceptive use and the incidence of cervical intraepithelial neoplasia.
  407. Oral contraceptives and cycle control: a critical review of the literature.
  408. Perceptions and knowledge about AIDS among family planning clinic attenders in Johannesburg.
  409. Prevalence of HIV-2 infection in a family planning clinic in Lisbon.
  410. The quality of family planning services in rural China.
  411. A quantitative assessment of oral contraceptive use and risk of ovarian cancer.
  412. Reference period analysis of vaginal bleeding with triphasic oral contraceptive agents containing norethindrone or levonorgestrel: a comparison study.
  413. Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives.
  414. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
  415. Teenagers seeking condoms at family planning services. Part I. A user's perspective.
  416. West Indian gender relations, family planning programs and fertility decline.
  417. Youth attending Cape Peninsula day hospitals. Sexual behaviour and missed opportunities for contraception counselling.
  418. The impact of family planning on women's lives: a conceptual framework and research agenda.
  419. The use of self-assessment in improving the quality of family planning clinic operations: the experience with COPE in Africa.
  420. Improving contraceptive supply management. [Améliorer la gestion des stocks de contraceptifs; Cómo mejorar la administración de los suministros de anticonceptivos.]
  421. Charging fees for family planning services. [Faire payer pour les services de planification familiale; El cobro de consultas de planificación familiar.]
  422. Evaluation of the Maternal-Child Health and Family Planning In-Service Training Program in Kenya. Final Report (condensed)
  423. Evaluation of the NEWVERN software component of the Family Planning Logistics Management II Project.
  424. An evaluation of the Scott Hospital Community Based Distribution Family Planning Programme.
  425. The Evaluation Project. Expert Meeting on Future Needs for Evaluating Family Planning Programs, September 11, 1992.
  426. Evidence from peninsular Malaysia of breastfeeding as a contraceptive method.
  427. Evolution of condom and oral contraceptive use in France. Survey. [Evolution de la consommation de preservatifs en France et de la contraception orale. (Enquete)]
  428. Evolution of family planning programs.
  429. An examination of available research on family planning in Burkina Faso. [Un examen de la recherche disponible sur la planification familiale au Burkina Faso.]
  430. Experience with a hormonal implant contraceptive. [Experiencia con un anticonceptivo hormonal de deposito.]
  431. An experiment using a month-by-month calendar in a family planning survey in Costa Rica.
  432. Exploring sociocultural barriers to family planning among Mayans in Guatemala.
  433. Extending family planning services through Third World women managers. Final report.
  434. Factors associated with contraception among high school adolescents in Nakuru district, Kenya.
  435. Factors associated with contraceptive behavior among black college students.
  436. Factors associated with the non-utilization of contraceptives in adolescence. [Fatores associados a nao-utilizacao de anticoncepcionais na adolescencia.]
  437. Faculty of Family Planning and Reproductive Health Care of the Royal College of Obstetricians and Gynaecologists [editorial]
  438. Failure in intrauterine contraception. Analysis of 137 cases of unfavourable outcome.
  439. Family planning among Zambian males: differences between Catholics and non-Catholics.
  440. Family planning and abortion in the Republic of Ireland. [Familienplanung und Abtreibung in der Republik Irland.]
  441. Family planning and child survival programs as assessed in 1991.
  442. Family Planning and Child Survival Survey, Ecuador 1989. Final English language report.
  443. Family planning and PHC programme.
  444. Family planning and PHC programme.
  445. Family planning and reproductive health: support to technical collaboration between developing countries.
  446. Family planning and rumours.
  447. Family planning and the Directorate of Religious Affairs.
  448. Family planning and the mothers of the town of Toamasina (1988) [Planification familiale et les meres de la ville de Toamasina (1988)]
  449. Family planning and the pill. Practical points.
  450. Family planning and the rights of existence and development of the Chinese people.
  451. Family Planning Association of Kenya: increasing male involvement and participation in family planning programmes.
  452. Family planning associations and AIDS. [Les associations de planification familiale et le Sida.]
  453. Family planning behavior of minors doubted [letter]
  454. Family planning centers: goal setting, development, perspectives. [Familienplanungszentren: Zielsetzung, Entwicklung, Perspektiven.]
  455. Family planning counseling: an international conference.
  456. Bangladesh NGO family planning evaluation, 1990: key results and lessons learned.
  457. Barrier contraceptives.
  458. Barrier methods of contraception and cervical intraepithelial neoplasia.
  459. Barriers to contraceptive development in the United States.
  460. Baseline family planning survey of men in Mombasa and Nairobi, Kenya, May, 1992.
  461. A baseline situation analysis of family planning provider and client IEC in Kenya.
  462. Behavior change strategies for family planning.
  463. Benefits and risks of hormonal contraception. [Nutzen und Risiko der hormonellen Kontrazeption.]
  464. Benefits and risks of oral contraceptive use.
  465. Benefits of family planning. [Beneficios de la planificacion familiar.]
  466. Beyond birth control.
  467. Beyond TOT: creating and sustaining organizational change in the Nigerian Family Planning Program.
  468. A bibliographic inventory on mother and child, family planning, maternal and child health, nutrition, and demography in Madagascar. [Inventaire bibliographique sur la femme et l'enfant, planification familiale, sante maternelle et infantile, nutrition, demographie a Madagascar.]
  469. Biodegradable block copolymer matrices for long-acting contraceptives with constant release.
  470. Biosocial trends at first pregnancy in Mexican women not exposed to contraceptive methods.
  471. Birth control and free choice in Brazil.
  472. Birth control and social class: contraception, accidental pregnancies, and abortion. [Maitrise de la fecondite et appartenance sociale: contraception, grossesses accidentelles et avortements.]
  473. Birth control as a social dilemma.
  474. Birth control knowledge high, but practice varies in developing countries.
  475. Birth control pills, cigarettes, alcohol linked to liver cancer.
  476. Birth control update for childbirth educators.
  477. Birth control vaccines: the progress continues.
  478. Birth control's other mother.
  479. Birth control.
  480. Birth control. A shot in the arm for the planners.
  481. Bound and gagged: America's family planning network.
  482. Breast cancer detection in relation to oral contraception.
  483. Breastfeeding and natural family planning.
  484. Breastfeeding, family planning and child health -- final comments.
  485. Breastfeeding, lactational infecundity, contraception and the spacing of births: implications of the Bellagio Consensus Statement.
  486. Bringing family planning to isolated Ecuadorians.
  487. Cameroonian nurses' perceptions of family planning: implications for nursing practice.
  488. Can family planning succeed in Pakistan?
  489. Canada's first birth control clinic: the Birth Control Society of Hamilton 1931-1940.
  490. Carbohydrate metabolism after three months of using a gestodene-containing monophasic oral contraceptive.
  491. Linking AIDS and family planning [letter]
  492. Lipid and biochemical changes after low-dose oral contraception.
  493. Local institutions for the family planning program.
  494. Long term use of inert intrauterine contraceptive devices in 94 women in Israel.
  495. Long-term effect of low-dose combined steroid contraceptives on body iron status.
  496. A longitudinal evaluation of computer-assisted instruction on contraception for college students.
  497. Low-doses oral contraception benefits women over 40.
  498. Maintenance payments for child support in Southern Africa: using law to promote family planning.
  499. Making good use of nature's contraceptive.
  500. Male and female barrier contraceptives as protection against STDs.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.